Production (Stage)
EGF Theramed Health Corp.
EVAHF
$0.026
-$0.021-44.68%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 2.30K | 2.30K | 2.30K | 2.30K | -- |
| Gross Profit | -2.30K | -2.30K | -2.30K | -2.30K | -- |
| SG&A Expenses | 173.60K | 167.60K | 157.00K | 167.80K | 185.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 175.90K | 169.90K | 159.30K | 170.10K | 185.20K |
| Operating Income | -175.90K | -169.90K | -159.30K | -170.10K | -185.20K |
| Income Before Tax | -316.90K | -319.50K | -195.10K | -218.50K | -246.80K |
| Income Tax Expenses | 3.10K | 3.10K | -- | -- | -- |
| Earnings from Continuing Operations | -0.32 | -0.32 | -0.20 | -0.22 | -0.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 26.00K | 29.80K | 14.60K | 20.00K | 16.40K |
| Net Income | -294.00K | -292.80K | -180.50K | -198.60K | -230.30K |
| EBIT | -175.90K | -169.90K | -159.30K | -170.10K | -185.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 46.16M | 45.93M | 45.71M | 44.85M | 43.95M |
| Average Diluted Shares Outstanding | 46.16M | 45.93M | 45.71M | 44.85M | 43.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |